ConductScience.org, home

Paper39014454

Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework.

Cheng Y and 12 others. CNS Neurosci Ther, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework. Papers, record 39014454. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39014454

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework.
PubMed
Journal
CNS Neurosci Ther
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.13, provisional
iCite
Revised in PubMed
2025-07-29
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cheng YYuan
2Chen SFShu-Fen
3Zhang YRYa-Ru
4Guo YYu
5Wu KMKai-Min
6Huang YYYu-Yuan
7Aerqin QQiaolifan
8Kuo KKevin
9Li HQHong-Qi
10Chen SDShi-Dong
11Liu WSWei-Shi
12Dong QQianghttps://orcid.org/0000-0002-3874-0130
13Yu JTJin-Taihttps://orcid.org/0000-0002-2532-383X

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
tau ProteinsMajor topic
Amyloid beta-PeptidesMajor topic
DementiaMajor topic
BiomarkersMajor topic
Disease ProgressionMajor topic
Humans
Male
Female
Aged
Middle Aged
Prognosis
Creutzfeldt-Jakob Syndrome
Peptide Fragments
Alzheimer Disease
Aged, 80 and over

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2019074Shanghai Talent Development Funding for The ProjectPubMed
21QA1408700Shanghai Rising Star ProgramPubMed
2022ZD0211600Science and Technology Innovation 2030 Major ProjectsPubMed
2018SHZDZX01Shanghai Municipal Science and Technology Major ProjectPubMed
2022QD002Research Start up Fund of Huashan HospitalPubMed
3030277001Excellence 2025 Talent Cultivation Program at Fudan UniversityPubMed
ZHANGJIANG LABPubMed
Tianqiao and Chrissy Chen InstitutePubMed
the State Key Laboratory of Neurobiology and Frontiers Center for Brain Science of Ministry of EducationPubMed

Source PubMed

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135258587One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study.JAMA Neurol2022https://conductscience.org/library/papers/35258587PubMed
235388668Laboratory Diagnosis of Creutzfeldt-Jakob Disease.N Engl J Med2022https://conductscience.org/library/papers/35388668PubMed
335508635Rapidly progressive dementias - aetiologies, diagnosis and management.Nat Rev Neurol2022https://conductscience.org/library/papers/35508635PubMed
435700125Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults: The CABLE Study.Ann Neurol2022https://conductscience.org/library/papers/35700125PubMed
519773352Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.Brain2009https://conductscience.org/library/papers/19773352PubMed
637858957Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.Alzheimers Dement2024https://conductscience.org/library/papers/37858957PubMed
738306599Evaluation of ATNPD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease.Neurology2024https://conductscience.org/library/papers/38306599PubMed
835735602Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis.Eur J Neurol2022https://conductscience.org/library/papers/35735602PubMed
921514250The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Alzheimers Dement2011https://conductscience.org/library/papers/21514250PubMed
1010720281Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.Neurology2000https://conductscience.org/library/papers/10720281PubMed
1128205010Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.Acta Neuropathol2017https://conductscience.org/library/papers/28205010PubMed
1229368621The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.Alzheimers Res Ther2018https://conductscience.org/library/papers/29368621PubMed
1334239130Developing the ATX(N) classification for use across the Alzheimer disease continuum.Nat Rev Neurol2021https://conductscience.org/library/papers/34239130PubMed
1435306613Biofluid Biomarkers of Alzheimer's Disease: Progress, Problems, and Perspectives.Neurosci Bull2022https://conductscience.org/library/papers/35306613PubMed
1534027020P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status.Alzheimers Dement (Amst)2021https://conductscience.org/library/papers/34027020PubMed
1624174584Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.Neurology2013https://conductscience.org/library/papers/24174584PubMed
1730675918Development of the clinical assessment scale in autoimmune encephalitis.Ann Neurol2019https://conductscience.org/library/papers/30675918PubMed
1819307538CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.Neurology2009https://conductscience.org/library/papers/19307538PubMed
1924978677Review: Laboratory diagnosis and surveillance of Creutzfeldt-Jakob disease.J Med Virol2015https://conductscience.org/library/papers/24978677PubMed
2037740924ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.Alzheimers Dement2024https://conductscience.org/library/papers/37740924PubMed

See all 39 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42395347Striatal functional connectivity alterations in mild cognitive impairment subtypes defined by CSF A/T biomarkers.Front Aging Neurosci2026https://conductscience.org/library/papers/42395347PubMed
42022560Conformationally locked 7-aryl tetrahydroisoquinolines as dual acetylcholinesterase inhibitors and antioxidants: role of intramolecular hydrogen bonding and aryl electronics.Front Pharmacol2026https://conductscience.org/library/papers/42022560PubMed
41705131Alterations in functional connectivity of the anterior cingulate cortex associated with different levels of tau and amyloid-β deposition in patients with mild cognitive impairment.Front Neurosci2026https://conductscience.org/library/papers/41705131PubMed
41591813Evaluating Physical Frailty as a Marker of Cognitive Health in Older Adults without Dementia.J Geriatr Psychiatry Neurol2026https://conductscience.org/library/papers/41591813PubMed
40824589Neuroglial biomarkers in autoimmune encephalitis: advances in diagnosis, prognosis, and pathophysiological insights.Neurol Sci2025https://conductscience.org/library/papers/40824589PubMed
39014454Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework.CNS Neurosci Ther2024https://conductscience.org/library/papers/39014454PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39014454

GET https://conductscience.org/api/papers/v1/39014454/references?page=2